Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that propose the development of therapeutic agents for disorders that fall under the mission of NIAAA.
An identified candidate, having sufficient bioactivity,
stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required prior to application.
The FOA supports Investigational New Drug (IND)-enabling studies for the therapeutic candidate.
At the end of the funding period, a successful project should have, at a minimum, an IND application submitted to the U. S. Food and Drug Administration (FDA).
The program supports early-phase clinical trials, although these are not required.
An identified candidate, having sufficient bioactivity,
stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required prior to application.
The FOA supports Investigational New Drug (IND)-enabling studies for the therapeutic candidate.
At the end of the funding period, a successful project should have, at a minimum, an IND application submitted to the U. S. Food and Drug Administration (FDA).
The program supports early-phase clinical trials, although these are not required.
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $4,000,000
Office: National Institutes of Health
Estimated Funding: $4,000,000
Who's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-18-578.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PAR-18-578.html
Contact:
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
Date Posted:
2018-01-12
Application Due Date:
Archive Date:
2021-01-09
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
